Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

Michael B Hovater,1 Edgar A Jaimes1,2 1Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Department of Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL, USA Abstract: High blood pressure is the leading risk...

Full description

Bibliographic Details
Main Authors: Hovater MB, Jaimes EA
Format: Article
Language:English
Published: Dove Medical Press 2013-06-01
Series:Integrated Blood Pressure Control
Online Access:http://www.dovepress.com/optimizing-combination-therapy-in-the-management-of-hypertension-the-r-a13339
_version_ 1818043587658514432
author Hovater MB
Jaimes EA
author_facet Hovater MB
Jaimes EA
author_sort Hovater MB
collection DOAJ
description Michael B Hovater,1 Edgar A Jaimes1,2 1Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Department of Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL, USA Abstract: High blood pressure is the leading risk factor for death and disability worldwide, and the prevalence is increasing. Effective treatment decreases the risk of adverse events in proportion to blood pressure reduction. Combination antihypertensive therapy reduces blood pressure promptly and effectively. Single-pill combinations reduce the pill burden and improve adherence, efficacy, and tolerability of treatment compared with single drug pills. A significant portion of the hypertensive population will require three drugs for adequate control. The single-pill combination of aliskiren, amlodipine, and hydrochlorothiazide is based on complementary mechanisms of action. Clinical trials have shown it to be a safe and effective treatment for hypertension. This combination is a reasonable choice in clinical practice for patients with hypertension that requires three drugs for effective treatment. Keywords: aliskiren, amlodipine, hydrochlorothiazide, Amturnide, hypertension, combination
first_indexed 2024-12-10T09:04:35Z
format Article
id doaj.art-d31539bcbf2940f5a90a78e26210767d
institution Directory Open Access Journal
issn 1178-7104
language English
last_indexed 2024-12-10T09:04:35Z
publishDate 2013-06-01
publisher Dove Medical Press
record_format Article
series Integrated Blood Pressure Control
spelling doaj.art-d31539bcbf2940f5a90a78e26210767d2022-12-22T01:55:11ZengDove Medical PressIntegrated Blood Pressure Control1178-71042013-06-012013default5967Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combinationHovater MBJaimes EAMichael B Hovater,1 Edgar A Jaimes1,2 1Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Department of Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL, USA Abstract: High blood pressure is the leading risk factor for death and disability worldwide, and the prevalence is increasing. Effective treatment decreases the risk of adverse events in proportion to blood pressure reduction. Combination antihypertensive therapy reduces blood pressure promptly and effectively. Single-pill combinations reduce the pill burden and improve adherence, efficacy, and tolerability of treatment compared with single drug pills. A significant portion of the hypertensive population will require three drugs for adequate control. The single-pill combination of aliskiren, amlodipine, and hydrochlorothiazide is based on complementary mechanisms of action. Clinical trials have shown it to be a safe and effective treatment for hypertension. This combination is a reasonable choice in clinical practice for patients with hypertension that requires three drugs for effective treatment. Keywords: aliskiren, amlodipine, hydrochlorothiazide, Amturnide, hypertension, combinationhttp://www.dovepress.com/optimizing-combination-therapy-in-the-management-of-hypertension-the-r-a13339
spellingShingle Hovater MB
Jaimes EA
Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
Integrated Blood Pressure Control
title Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
title_full Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
title_fullStr Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
title_full_unstemmed Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
title_short Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
title_sort optimizing combination therapy in the management of hypertension the role of the aliskiren amlodipine and hydrochlorothiazide fixed combination
url http://www.dovepress.com/optimizing-combination-therapy-in-the-management-of-hypertension-the-r-a13339
work_keys_str_mv AT hovatermb optimizingcombinationtherapyinthemanagementofhypertensiontheroleofthealiskirenamlodipineandhydrochlorothiazidefixedcombination
AT jaimesea optimizingcombinationtherapyinthemanagementofhypertensiontheroleofthealiskirenamlodipineandhydrochlorothiazidefixedcombination